21st Century buys non-invasive glucose meter:
This article was originally published in Clinica
Twenty First Century Health has purchased the North American rights to a non-invasive test for glycosolated haemoglobin from Milton Fuller. The company, which is based in Las Vegas, Nevada, also acquired joint rights to the European market. Twenty First Century says it will develop a home and hospital-use device about 4.5" X 3" X 2" which will retail for $500.
You may also be interested in...
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.
Strong top-line efficacy in pyruvate kinase deficiency patients who don’t receive regular transfusions looks approvable, analysts say, but Agios will await data in regularly transfused patients.